BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
134 hedge funds and large institutions have $1.39B invested in Blueprint Medicines in 2017 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 50 increasing their positions, 27 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
30% more funds holding
Funds holding: 103 → 134 (+31)
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
23.39% more ownership
Funds ownership: 80.56% → 103.96% (+23%)
Holders
134
Holding in Top 10
9
Calls
$2.84M
Puts
$1.94M
Top Buyers
| 1 | +$102M | |
| 2 | +$82M | |
| 3 | +$51M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$37.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$36.2M |
Top Sellers
| 1 | -$46.1M | |
| 2 | -$19.1M | |
| 3 | -$9.67M | |
| 4 |
SH
Sandia Holdings
Greenwich,
Connecticut
|
-$8.34M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$6.8M |